Not everyone is high on the news this week that JPMorgan Chase unit One Equity Partners acquired health technology vendor M-Modal for $1.1 billion. According to The Tennessean, many analysts have wondered why M-Modal sold for only $14 a share in cash.
"The question everybody's asking is what's there that we're missing?" analyst Leo Carpio told the newspaper. "Why are they selling themselves at so low a price?" Carpio said he thought the company could have been sold for at least $18 a share. Article